STATE-OF-THE-ART PAPER
Valvular Heart Disease and Pregnancy
Part II: Prosthetic Valves
Uri Elkayam, MD, FACC* and
Fahed Bitar, MD
Heart Failure Program, Division of Cardiovascular Medicine, University of Southern California, Keck School of Medicine, Los Angeles, California
Manuscript received January 28, 2005;
accepted February 8, 2005.
* Reprint requests and correspondence: Dr. Uri Elkayam, Heart Failure Program, Keck School of Medicine, Los Angeles County/University of Southern California Medical Center, Room 7621, 1200 North State Street, Los Angeles, California 90033 (Email: elkayam{at}usc.edu).
A large number of prosthetic heart valves (PHV) are being implanted in patients with both congenital and acquired valvular disease. Many of the recipients of such valves are women of childbearing age who desire to have children. The main issues involved with pregnancy in a patient with PHV include the selection of PHV in women during their childbearing age, risks to both the mother and the fetus associated with pregnancy and the management of the patients with PHV during gestation.
|
Abbreviations and Acronyms
| | ACCP = American College of Chest Physicians | | aPTT = activated partial thromboplastin time | | LMWH = low molecular weight heparin | | PHV = prosthetic heart valve | | SVD = structural valve deterioration | | UFH = unfractionated heparin |
|
This article has been cited by other articles:
|
|
|
|
 
Endorsed by the European Society of Gynecology (ES, Authors/Task Force Members, V. Regitz-Zagrosek, C. Blomstrom Lundqvist, C. Borghi, R. Cifkova, R. Ferreira, J.-M. Foidart, J. S. R. Gibbs, C. Gohlke-Baerwolf, et al.
ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)
Eur. Heart J.,
December 2, 2011;
32(24):
3147 - 3197.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Chitsike Rufaro Saeed, J. B. Frank, M. Pravin, Rhemtula Haroun Aziz, M. Serasheini, and T. Gabrielle Dominique
A Prospective Trial Showing the Safety of Adjusted-Dose Enoxaparin for Thromboprophylaxis of Pregnant Women With Mechanical Prosthetic Heart Valves
Clinical and Applied Thrombosis/Hemostasis,
August 1, 2011;
17(4):
313 - 319.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. Sillesen, V. Hjortdal, N. Vejlstrup, and K. Sorensen
Pregnancy with prosthetic heart valves -- 30 years' nationwide experience in Denmark
Eur J Cardiothorac Surg,
August 1, 2011;
40(2):
448 - 454.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Soma-Pillay, Z. Nene, T. M. Mathivha, and A. P. Macdonald
The effect of warfarin dosage on maternal and fetal outcomes in pregnant women with prosthetic heart valves
Obstet Med,
March 1, 2011;
4(1):
24 - 27.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Appendix
OSH Valvular Heart Disease,
January 1, 2011;
1(1):
med-9780199559237-appendi - med-9780199559237-appendi.
[Full Text]
|
|
|
|
|
|
|
P. Presbitero, D. Zavalloni, and B. Agnoli
Chapter 61 Cardiac emergencies in pregnancy
The ESC Textbook of Acute and Intensive Cardiac Care,
December 1, 2010;
1(1):
med-9780199584314-chapter - med-9780199584314-chapter.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Drenthen, E. Boersma, A. Balci, P. Moons, J. W. Roos-Hesselink, B. J. M. Mulder, H. W. Vliegen, A. P. J. van Dijk, A. A. Voors, S. C. Yap, et al.
Predictors of pregnancy complications in women with congenital heart disease
Eur. Heart J.,
September 1, 2010;
31(17):
2124 - 2132.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. E. Bowater and S. A. Thorne
Management of pregnancy in women with acquired and congenital heart disease
Postgrad. Med. J.,
February 1, 2010;
86(1012):
100 - 105.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Carrascal
eComment: Are low molecular weight heparin effective in mechanical valve prosthesis anticoagulation during pregnancy?
Interact CardioVasc Thorac Surg,
January 1, 2010;
10(1):
118 - 119.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Pibarot and J. G. Dumesnil
Prosthetic Heart Valves: Selection of the Optimal Prosthesis and Long-Term Management
Circulation,
February 24, 2009;
119(7):
1034 - 1048.
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. M. Jeejeebhoy
Prosthetic heart valves and management during pregnancy
Can Fam Physician,
February 1, 2009;
55(2):
155 - 157.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al.
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
Circulation,
October 7, 2008;
118(15):
e523 - e661.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol.,
September 23, 2008;
52(13):
e1 - e142.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. P Akhtar, A. R Abid, H. Zafar, M. A Cheema, and J. S Khan
Anticoagulation in Pregnancy with Mechanical Heart Valves: 10-Year Experience
Asian Cardiovasc Thorac Ann,
December 1, 2007;
15(6):
497 - 501.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. De Caterina, S. Husted, L. Wallentin, G. Agnelli, F. Bachmann, C. Baigent, J. Jespersen, S. D. Kristensen, G. Montalescot, A. Siegbahn, et al.
Anticoagulants in heart disease: current status and perspectives
Eur. Heart J.,
April 10, 2007;
(2007)
ehl492v1.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Authors/Task Force Members, A. Vahanian, H. Baumgartner, J. Bax, E. Butchart, R. Dion, G. Filippatos, F. Flachskampf, R. Hall, B. Iung, et al.
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology
Eur. Heart J.,
January 26, 2007;
(2007)
ehl428v1.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol.,
August 1, 2006;
48(3):
e1 - e148.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol.,
August 1, 2006;
48(3):
598 - 675.
[Full Text]
[PDF]
|
|
|
|
